Why Emergent BioSciences Stock Plummeted Today
Emergent BioSolutions (NYSE: EBS) saw its shares tumble on Tuesday, due to news of a share sell-off. The vaccine maker divulged in a regulatory filing that several institutional share and warrant holders...
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks
Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.
10 Stocks Retailers On Stocktwits Are Most Bullish/Bearish About To Start The Week
As the new week unfolds, earnings and economic data will again dictate sentiment.
Emergent Biosolutions Stock Soars After Q3 Earnings: Retail Sentiment Strong
Earnings per share for Q3 came in at $1.37, compared to consensus estimates of $0.10.
Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript
EBS earnings call for the period ending September 30, 2024.
Emergent Biosolutions: Q3 Earnings Snapshot
Emergent Biosolutions: Q3 Earnings Snapshot